loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of GATTEX KIT reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    GATTEX KIT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,798,327Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7Gattex/Revestive

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Gattex/Revestive

    Teduglutide

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Gattex/Revestive

    Japan
    arrow
    Luxepack
    Not Confirmed

    Takeda

    Teduglutide

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2019 Revenue in Millions : 555

    2018 Revenue in Millions : 0

    Growth (%) : N/A

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Gattex/Revestive

    Teduglutide

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Gattex/Revestive

    Japan
    arrow
    Luxepack
    Not Confirmed

    Takeda

    Teduglutide

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2020 Revenue in Millions : 617

    2019 Revenue in Millions : 566

    Growth (%) : 9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Gattex/Revestive

    Teduglutide

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Gattex/Revestive

    Japan
    arrow
    Luxepack
    Not Confirmed

    Takeda

    Teduglutide

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2021 Revenue in Millions : 599

    2020 Revenue in Millions : 592

    Growth (%) : 9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Gattex/Revestive

    Teduglutide

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Gattex/Revestive

    Japan
    arrow
    Luxepack
    Not Confirmed

    Takeda

    Teduglutide

    Main Therapeutic Indication : Gastrointestinal Diseases

    Currency : USD

    2022 Revenue in Millions : 750

    2021 Revenue in Millions : 599

    Growth (%) : 25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Gattex/Revestive

    Teduglutide

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Gattex/Revestive

    Japan
    arrow
    Luxepack
    Not Confirmed

    Takeda

    Teduglutide

    Main Therapeutic Indication : Gastrointestinal Diseases

    Currency : USD

    2023 Revenue in Millions : 715

    2022 Revenue in Millions : 750

    Growth (%) : 8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Gattex/Revestive

    Teduglutide

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Gattex/Revestive

    Ireland
    arrow
    Luxepack
    Not Confirmed

    Shire

    Teduglutide

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2016 Revenue in Millions : 219

    2015 Revenue in Millions : 142

    Growth (%) : 54

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Gattex/Revestive

    Teduglutide

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Gattex/Revestive

    Ireland
    arrow
    Luxepack
    Not Confirmed

    Shire

    Teduglutide

    Main Therapeutic Indication : Gastrointestinal Disorders

    Currency : USD

    2017 Revenue in Millions : 336

    2016 Revenue in Millions : 219

    Growth (%) : 53

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF